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A B S T R A C T
Inflammatory and genetic alterations are related to the development of chronic diseases such 
as cancer. Schinus terebinthifolius Raddi, Anacardiaceae, is used in folk medicine to treat in-
flammation, wounds and tumors. This study evaluated the anti-inflammatory, immunomod-
ulatory, chemopreventive, and wound healing potentials of the methanolic extract from the 
leaves of Schinus terebinthifolius. The chemical composition of the extract was characterized 
using preliminary analytical LC methods. The results showed that the anti-inflammatory ac-
tivity of the methanolic extract was similar to that of dexamethasone for edema reduction. 
Also, it inhibited the leukocyte migration into the air pouch and decreased plasma extrava-
sation. In addition, the methanolic extract showed a healing action similar to that observed 
with collagenase. The methanolic extract is not genotoxic nor mutagenic, and in contrast it 
has chemopreventive activity, which elicits a high percentage of damage reduction by comet 
and micronucleus assay, preferably by bioantimutagenic action. The methanolic extract in-
duced apoptosis and enhanced splenic phagocytosis in animals treated with cyclophospha-
mide. The methanolic extract contents, resolved by LC, include phenolic acid and flavonoids. 
Our results suggest a therapeutic potential for the methanolic extract.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction
Schinus terebinthifolius Raddi, Anacardiaceae, popularly known 
as “aroeira-vermelha”, “aroeira-pimenteira”, “Brazilian pepper” 
or “Christmas-berry” is an evergreen tree, native to Brazil, 
introduced in different parts of the world as South and Central 
America, Mediterranean Europe, Africa and the United States 
(Barbosa et al., 2007; El-Massry et al., 2009).
In popular medicine, stem bark and leaves of S. terebinthifolius 
are mainly used in the form of decoction or infusion (El-Massry 
et al., 2009) for the treatment of bacterial infections (Martinez 
et al., 1996; El-Massry et al., 2009), wound healing, anti-
inflammatory and as an anti-ulcer agent (Martorelli et al., 
2011; Santana et al., 2012). Moreover, S. terebinthifolius has 
antioxidant and anti-tumor activities (Queires et al., 2006, De 
Mesquita et al., 2009; El-Massry et al., 2009), due to the high 
content of phenolic compounds characteristic of the species, 
such as tannins, gallic acid and flavonoids (Queires et al., 2006; 
Ceruks et al., 2007; Santana et al., 2012). 
It has been well documented in the literature that tissue 
damage determines the development of inflammation and 
wound healing process, by mechanisms that include the 
production of chemical mediators, the recruitment of specific 
cells and an increased rate of cell division. These inflammatory 
mediators, when present in excess, inhibit apoptosis (Barreto et 
al., 2011), leading to the loss of tissue homeostasis, which favors 
the onset of mutations that could lead to cancer development 
(Valko et al., 2007; Formagio et al., 2013b). Additionally, changes 
in the antioxidant defenses (counterbalance of free radical 
activities) of the organism relate also to the genetic/chromosome 
instability and the inflammation process, which show a strong 
relationship among the triad: inflammation x genetic instability 
x antioxidant action (Valko et al., 2007; Formagio et al., 2013a). 
Taking this into account, the present investigation evaluated 
the anti-inflammatory, immunomodulatory, chemopreventive 
and wound healing potentials of the S. terebinthifolius methanolic 
extract (MEST).
Material and methods
Plant material
S. terebenthifolius Raddi, Anacardiaceae, leaves were collected 
in June 2012 at the Botanical Garden of Federal University of 
Grande Dourados (UFGD). This area is located in the southern 
region of Mato Grosso do Sul, with an average altitude of 
452 m; and coordinates 22°14’16” S latitude and 54°49’2” W 
longitude. The plant was identified by Maria do Carmo Vieira 
and a voucher specimen was deposited (# 4602) at the UFGD 
Herbarium.
Preparation of extract
S. terebenthifolius leaves were air-dried at 40°C for 4 days and 
the dried plant was cut and pulverized. The plant material was 
macerated for 7 days using methanol as solvent. The solvent 
was then eliminated using a rotary vacuum evaporator under 
reduced pressure and it was further lyophilized, representing 
a yield of 7.92% of the methanolic extract.
LC analysis of standards and samples
The extract obtained from the samples and standards were 
analyzed using an analytical LC (Varian 210) system with 
a ternary solvent delivery system equipped with an auto-
sampler, a photodiode array detector (PDA) monitored 
at O200-800 nm. The LC column was a C-18 (25 cm × 4.6 
mm; particle size, 5 μm; Luna, Phenomenex, Torrance, CA, 
USA), with a small pre-column (2.5 cm × 3 mm) containing 
the same packing material, used to protect the analytical 
column. For each analysis, the flow rate and the injected 
volume were set as 1.0 ml.min-1 and 20 μl, respectively. All 
chromatographic analyses were performed at 22°C. Elution 
was carried out using acetic acid (6%), and sodium acetate 
(2 mM) (solvent A) and acetonitrile (solvent B). The solvent 
gradient program was carried as follows: 0 min, 5% B; 45 
min, 15%; 55 min, 50% B, 60 min; 65 min, 100% B and in 70 
min returning to the initial.
Reagents
Spectroscopy grade acetonitrile was purchased from Merck 
(Darmstadt). Stock mixture of standards were constituted from 
individual solution, dissolved in acetonitrile and then used as 
external standard. Standards [caffeic acid (98%), p-coumaric 
acid (98%), luteolin (98%), quercetin (98%) and apigenin (95%)] 
were purchased from Sigma Aldrich.
Linearity
The standards content estimation in the samples was 
performed by external calibration. Aliquots of 20 μl of the 
dilutions were analyzed via LC, and each determination was 
carried out five times. For the standard, the corresponding 
chromatogram was obtained and a graph was constructed 
from the mean of the chromatogram areas plotted against 
the standards in concentration of the 1-50 μg.ml-1. A linear 
least squares regression was performed for the peak areas 
as a function of concentrations to determine the correlation 
coefficients. The equation parameters (slope and intercept) 
of the standard curve were used to obtain the concentration 
values of the samples.
Experiment 1
Evaluation of the anti-inflammatory and wound healing 
properties of S. terebenthifolius
The experiments were conducted using male Swiss mice 
(25-35 g) or male Wistar rats (200-250 g) provided by UFGD. 
The animals were maintained under a 12 h light-dark cycle, 
under controlled humidity (60-80%), and temperature (22° ± 
1°C). The animals were acclimatized to the experimentation 
room for at least 2 h before testing and were used only 
once throughout the experiments (n = 5/group). All 
experimental procedures were carried out in accordance 
with U.S. National Institute of Health, and were approved 
for research by the ethics committee on laboratory animal 
of UFGD (# 005/2010).
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Wound creation, animal grouping and drug administration 
in rats
The backs of the rats were shaved, and 8 mm full thickness 
open excision wound was made by removing a patch 
of skin. Animals were anesthetized with ketamine and 
xylazine (intraperitoneal route) (Suguna et al., 1999). A total 
of 24 animals were divided into three groups: the control 
group that received only vehicle solution, MEST group and 
commercial colagenase group (that received Iruxol®, topical 
application). The control rats received 50 μl of unbuffered 
physiological saline, once daily, for a period of 11 days. 
The MEST rats received 50 μl of MEST (80 mg/ml, diluted 
with unbuffered physiological saline), applied topically, 
once daily, for a period of 11 days; while the commercial 
collagenase group received 50 μl of Iruxol. The wound 
closure is expressed in mm.
Croton oil-induced ear oedema in mice
Twenty-five adult male mice were used in this assay. MEST (0.1, 
0.3 and 1 mg/ear), vehicle (acetone) or dexamethasone (0.2 mg/ear) 
were topically administered into the right ear of the mice 15 min 
prior to the application of croton oil. A total of 25 μl of 0.3% croton 
oil (dissolved in acetone) was topically applied to the inner surface 
of the right ear of each mouse. The left ear remained untreated 
as a negative control. Four and six hours after the administration 
of croton oil, the swelling induced by the phlogogen agent was 
measured using a digital micrometer in the right ear.
Air pouch model in mice
The air pouch model was performed as described by Garcia-
Ramallo et al. (2002), with some modifications. Swiss mice 
were anesthetized with ketamine and xylazine and 4 ml of 
sterile air was injected subcutaneously on their backs on 
day 0. On day 3, a second injection of 2 ml of sterile air was 
performed into the preformed pouch. On day 6, animals were 
treated with vehicle (Physiologic Saline), DEX (1 mg/kg s.c.) 
as positive control drug or MEST (100 mg/kg, p.o) (per oral 
route); and one hour later the inflammatory response was 
induced by injection of a solution of carrageenan 0.1% (350 
μl) directly into the pouch. Four hours after the inflammatory 
stimulus, the mice were euthanized and the pouches were 
washed with 1 ml of PBS/EDTA 10mM containing heparin. 
Exudates were collected and total cells were counted using 
a Neubauer chamber under light microscopy. Exudates were 
then centrifuged at 1000 g for 2 min at 4°C and the pellets 
suspended in 1 ml of 3 % albumin and added to previously-
prepared slides. Cells were stained using the May-Gruenwald-
Giemsa method, and analyzed under light microscopy; a total 
of 100 cells were counted. The supernatant obtained after 
exudate centrifugation was used to evaluate protein leakage 
to the inflammatory site. Protein levels were measured by 
Bradford´s reaction (Bradford, 1976). 
Experiment 2
Evaluation of the toxigenic, chemopreventive, immunomodulatory 
and apoptotic properties of S. terebenthifolius
The experiments were conducted using male Swiss mice (20-
30 g), provided by UFMS, divided into six experimental groups 
(n = 5). The animals were kept under a 12 h light-dark cycle, 
with controlled humidity (60-80%), and temperature (22° ± 1°C). 
The animals were acclimatized to the experimentation room 
for seven days. All experimental procedures were carried out 
in accordance with U.S. National Institute of Health, and were 
approved for research by the ethics committee on laboratory 
animals of UFMS (# 398/2012).
Cyclophosphamide (Fosfaseron®, Filaxis, Plot: D 06307), was 
used in these studies to induce DNA damage. It was diluted in 
0.9% saline and administered intraperitoneally (i.p.), at a dose 
of 100 mg/kg (0.1 ml/10 g) of body weight (bw). The MEST was 
administered by gavage (p.o.), at a dose of 16.8 mg/kg (bw), and 
it was dissolved in 1% methanol.
The treatment protocols were: (1) Negative control: 
t h e  a n i m a l s  r e c e i v e d  M E S T  ( 1 %  m e t h a n o l )  a n d 
cyclophosphamide (0.9% saline) vehicles at the first and 
second day of treatment. (2) Positive control: the animals 
received MEST and cyclophosphamide vehicles at the first 
day of treatment, and on the second day, they received 
the MEST vehicle and the cyclophosphamide. (3) MEST: the 
animals received MEST and cyclophosphamide vehicles 
on the first day, and on the second day, they received the 
cyclophosphamide vehicle and MEST. (4) Pre-treatment: 
the animals received MEST and cyclophosphamide 
vehicle at the first day and they received the MEST 
vehicle and cyclophosphamide on the second day. (5) 
Simultaneous treatment: the animals received the MEST 
and cyclophosphamide vehicles on the first day and on the 
second day they received both MEST and cyclophosphamide. 
(6) Post-treatment: on the first day animals received the 
MEST vehicle and the cyclophosphamide, and on the 
second day, they received MEST and the cyclophosphamide 
vehicle.
After treatment, the animals were weighed and euthanized 
by cervical dislocation. The spleen, kidneys, liver, heart and 
lungs were collected and weighed.
Toxigenic and chemopreventive evaluations: Comet assay and 
micronucleus in peripheral blood
To evaluate genotoxicity and antigenotoxicity, a comet assay 
was performed on peripheral blood according to method 
proposed by Singh et al. (1988) with modifications proposed 
by Oliveira et al. (2009). A sample of peripheral blood was 
collected by puncture of the tail vein 24 h (T1) after the last 
administration of the test compounds (cyclophosphamide or 
MEST). For each treatment, 100 cells were analyzed using a 
fluorescence microscope (Nikon), at 400 times of magnification, 
using an excitation bandpass of 420-490 nm, and barrier filter 
of 520 nm. The cells were classified as suggested by Kobayashi 
et al. (1995). 
To evaluate mutagenicity and antimutagenicity, the 
micronucleus test was performed as described by Hayashi et 
al. (1990) with modifications proposed by Oliveira et al. (2009) 
in peripheral blood. Blood samples were collected at 24 h 
(T1), 48 h (T2) and 72 h (T3) after treatment by caudal vein 
puncture. A total of 2000 cells were analyzed per animal using 
a fluorescence microscope (Bioval® L-2000A), at 400 times of 
magnification, using an excitation filter of 490 nm and barrier 
filter of 420-520 nm.
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Calculating the reduction of damage percentage
The chemopreventive activity of MEST was calculated by the 
percentage of DNA damage reduction (DR%).
 
Immunomodulatory evaluation: splenic phagocytosis and 
differential count of blood cells
The method described by Hayashi et al. (1990) with 
modifications by Ishii et al. (2011) was used to evaluate splenic 
phagocytosis. The animal’ spleens were macerated in 0.9% 
saline solution to obtain a homogeneous cell suspension. 
One hundred microliters of this material was deposited on a 
slide pre-stained with acridine orange (1 mg/ml) with a coated 
coverslip, and stored in a freezer until analysis. We analyzed 
200 cells/animal using a fluorescence microscope (Bioval® 
G-2000A) at 400 times magnification using an excitation filter 
(490 nm) and barrier filter (420-520 nm), and classified them 
by the presence or absence of phagocytosis, according to the 
description of Hayashi et al. (1990). 
In order to perform a differential cell count in peripheral 
blood, a drop of blood obtained by puncture of the tail vein 
72 h (T3) after treatment was collected. Blood was smeared on 
a microscope slide and it was air dried and subjected to rapid 
staining using the Panoptic Instant-Prov Kit. One hundred 
cells were analyzed per animal and neutrophils, monocytes, 
eosinophils and basophils were distinguished (Ishii et al., 2011) 
using an optical microscope (Microscope Physis, EXP 100), at 
1000 times magnification.
Assessment of apoptotic activity
The apoptosis assay was performed according to Mauro et 
al. (2011) with modifications. Fragments of spleen, liver and 
kidneys were macerated in 0.9% saline solution to obtain a 
homogeneous cell suspension. One hundred microliters of the 
solutions were used to do histological smear slides. The slides 
were air-dried and immersed afterwards in Carnoy’s fixative 
solution for 5 min and then they were quickly immersed in 
plates with decreasing concentrations of ethanol dilutions (95-
25%). The slides were washed in McIlvaine buffer for 5 min, 
stained with acridine orange (0.01%) for 3 min and washed in 
McIlvaine buffer. One thousand cells were analyzed per animal 
in a fluorescence microscope (Bioval® L-2000A), at 400 times of 
magnification, using excitation filter (490 nm) and barrier filter 
(420-520 nm). The cells were identified by DNA fragmentation 
patterns (Mauro et al., 2011). 
Statistical analyses
All data are presented as mean ± SEM. Differences between 
groups were evaluated by analyses of variance (one-way 
ANOVA) followed by Student Newman-Keuls test or Tukey’s 
test. Statistical differences were considered to be significant at 
p < 0.05. Graphs were drawn and statistical analysis was carried 
out using GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego, CA, USA).
Results
LC analysis
The methanolic extract of S. terebinthifolius (MEST) exhibited 
potential activities as determined by functional assays, and 
LC data was developed to identify the constituents of their 
leaves from specimens collected in Mato Grosso do Sul, Brazil 
(Fig. 1). Identification of the compounds with the aid of a PDA 
detector scanning in the spectral range of 200-800 nm did not 
reveal interferences in retention time of the samples in LC by 
the developed elution method. Standards were easily identified 
and quantified based on their absorption spectra in the UV 
region and by retention time. Standards found in the extracts 
were unambiguously identified by co-injection experiments 
in which aliquots of the extracts and standards were mixed 
and diluted to a known volume, and analyzed through LC. 
The calibration curves were determined by linear regression 
using LC. The linearity for standards was assessed for seven 
concentration ranges. The average standard errors for the 
peak areas of replicated injections (n = 5) were less than 1.5%, 
mean of postive control - mean of associated group
mean of positive control - mean of neagtive control
Figure 1 – LC-DAD chromatogram of methanolic extract of Schinus terebenthifolius leaves.
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Peak Standards Retention time (min) Content in
1 caffeic acid 14.78 206
2 p-coumaric acid 25.82 167
3 quercetin 62.08 378
4 luteolin 64.62 527
5 apigenin 66.99 403
MEST, Methanolic extract of S. terebinthifolius leaves; LC, Liquid 
Chromatography. 
Treatment
Mean area of closure of excision wound (mm)
Day 1 Day 3 Day 5 Day 11
Control 9.48 ± 1.04 7.99 ± 0.20 7.45 ± 0.18 3.23 ± 0.27
MEST 8.45 ± 0.22 7.07 ± 0.15 6.23 ± 0.32 2.33 ± 0.34*
Colagenase (ointment) 8.32 ± 0.34 7.80 ± 0.36 7.00 ± 0.32 2.15 ± 0.22*
MEST, Methanolic extract of S. terebinthifolius leaves; Mean ± S.E.M., Standard error of mean.  
*Asterisk means statistical significance in comparison to the control group p < 0.05.  
** p < 0.01 (Statistical Test, Analysis of Variance - one-way ANOVA/Student Newman-Keuls test). 
Table 1
Retention time of standards and contents in μg•g–1 of MEST 
in LC method.
Table 2
Effects of Schinus terebinthifolius methanolic extract on wound-healing.
thus showing good repeatability of the calibration curve. The 
respective coefficients of determination (r2) were 0.9994 for, 
caffeic acid and p-coumaric acid, and r2 = 0.9996 for luteolin, 
quercetin and apigenin. The retention time of standards and 
contents in samples are shown in Table 1.
Experiment 1 - Evaluation of the anti-inflammatory and wound 
healing properties of S. terebenthifolius
Effects of MEST on wound healing
The topical application of the MEST dose (80 mg/ml) 
significantly decreased the diameter of the wound made, with 
a contraction of 2.33 ± 0.34% after eleven days, as illustrated 
in Table 2.
Effects of MEST on croton oil-induced ear oedema
Topical application of croton oil to the ears of mice where oedema 
had been induced resulted in a significant increase in the weight 
of the treated right ear when compared with the untreated left ear. 
As shown in Fig. 2, the oral administration of MEST (0.1, 0.3 and 1 
mg/ear) reduced the ear oedema. The maximal inhibitions reached 
at 1 mg/ear were 29 ± 2% and 47 ± 2%, after 4 and 6 h after croton 
oil, respectively. The positive control dexamethasone (0.2 mg/ear) 
also inhibited ear oedema at 30 ± 3% after 4 h, and 50 ± 2% after 6 h.
Effects of MEST on carrageenan-induced leukocyte migration 
and plasma leakage to air pouches
On the sixth day after induction of air pouch on the dorsal 
region of mice, a carrageenan injection was applied (350 μl 
at 0.1%), which after 4 h, promoted a plasma leakage and 
leukocyte migration, principally by polymorphonuclear 
leukocytes (Fig. 3). The results were expressed as leukocytes 
× 107, and plasma leakage as mg of proteins/100 μl. The oral 
treatment of the animals with MEST significantly inhibited 
leukocyte migration to air pouches in 69 ± 5% at 100 mg/kg. 
MEST significantly inhibited plasma leakage, and the inhibition 
percentage was 55 ± 8%. DEX used as positive control, reduced 
Figure 2 – Effects of MEST at doses of 0.1, 0.3 and 1 mg/ear administered topically during croton oil-induced ear oedema model 
in mice. Each column represents the mean (n = 5), and the vertical lines show the S.E.M.A. 4h after croton oil application; B. 
6h after croton oil application. Asterisks denote the significance levels compared to the control values (croton oil): *p < 0.05 
and ***p < 0.001.
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about 67 ± 6% of leukocyte migration and 53 ± 7% the plasmatic 
extravasation.
Experiment 2 – Toxigenic, chemopreventive, immunomodulation 
and apoptotic evaluations
There was no body weight variation in all groups investigated, 
as showed in Table 3. A similar tendency for the relative 
weights of heart, lungs, liver and kidneys was observed. 
There was a reduction in the relative weight of the spleen in 
all groups that received cyclophosphamide.
Toxicogenic and chemopreventive evaluations: Comet assay and 
micronucleus in peripheral blood
The mean frequency of damaged cells, distribution among 
classes of damage and score related to genotoxicity and 
antigenotoxicity (comet assay) are presented in Table 4. There 
was absence of genotoxicity in the MEST group and decreased 
genotoxic damage was observed in all treatment protocols. The 
post-treatment group showed the highest DR (99.19%), with an 
average frequency of damaged cells (30.33 ± 12.45) similar to 
the Negative control group (30.00 ± 3.19). The DR% of the Pre-
treatment and simultaneous groups were 69.95 and 10.01%, 
respectively.
The total frequency, frequency mean and percentage 
of damage reduction related to mutagenicity and 
antimutagenicity tests (micronucleus) are presented in Table 
5. The micronucleus analysis indicated that MEST has no 
mutagenic activity and was effective in reducing the damage 
caused by cyclophosphamide in the groups analyzed, at 
different times, except for the pre-treatment group at T1. 
As it was observed, the chemopreventive activity displayed 
a time-dependent relationship, and there was an increased 
chemopreventive activity in the three analysis periods. The 
DR had a variation from 66.39% to 106.55% in T3.
Immunomodulatory evaluation: splenic phagocytosis and blood 
cells differential count
All data related to the splenic phagocytosis are illustrated in 
Table 6. The MEST group presented a higher (p < 0.05) incidence 
of splenic phagocytosis (138.25 ± 17.57) in comparison to the 
Negative control (111.8 ± 5.68). The pre-treatment (98.40 ± 
5.19), simultaneous (88.40 ± 3.30) and post-treatment (82.00 
± 5.96) groups showed a trend of increased phagocytosis in 
comparison to the Positive control (68.75 ± 5.08).
The differential blood cell counts are presented in Table 
7. Cell counts were similar between controls and treated 
groups, and the values are within the reference ranges, except 
for eosinophils, that present a slight increase in the negative 
control, MEST, pre-and post-treatment groups.
Assessment of apoptotic activity
All data related to apoptosis are illustrated in Table 8. The 
MEST when administered alone does not induce an increase 
in the frequency of apoptosis in liver, spleen and kidneys. 
Cyclophosphamide increased the frequency of apoptosis in 
the order of 3.11, 9.20 and 4.65 times in the liver, spleen and 
kidney, respectively. When cyclophosphamide was associated 
with MEST there was a decrease (p < 0.05) in the frequency of 
apoptosis in spleen, and an increase (p < 0.05) in the frequency 
of apoptosis in kidney. With the exception of post-treatment 
group, a tendency of increased apoptosis in liver was observed 
(Table 8).
Discussion
Medicinal plants are used to cure and/or prevent diseases, 
and they constitute a major source for the discovery of 
new therapeutic agents (Formagio et al., 2013a). Schinus 
terebinthifolius Raddi, Anacardiaceae, is a plant popularly used 
for the treatment of inflammation, infections, wounds, ulcers 
and tumors (Santana et al., 2012). 
Previous studies using wound-heal ing models , 
demonstrated that the hydroethanolic extract from the 
leaves of S. terebinthifolius were effective for wounds on the 
tongue mucous of rats, and in the healing process of the alba 
linea (Nunes-Jr et al., 2006) surgical wounds (Coutinho et 
al., 2006) and cutaneous wound (Martorelli et al., 2011). The 
wound response were significantly ameliorated in all rodent 
models and the present study corroborated and extended 
these findings proving that the contraction of the wounds 
Figure 3 – Effect of MEST at dose 100 mg/kg on carrageenan-
induced leukocyte migration and plasma leakage into the 
air pouch. Each column represents the mean (n = 5), and the 
vertical lines show the S.E.M. Cells were counted and plasma 
leakage was analyzed. A. Number of cells that migrates to the 
pouches 4h after carrageen an. Results are expressed as cell 
107/cavity. B. Plasma leakage was measured by Bradford´s 
reaction. Results are expressed as protein/mg-1 of protein. 
*p < 0.05; ***p < 0.001; compared to the vehicle group. 
Differences between groups were analyzed by analysis of 
variance (One-way ANOVA) followed by Newman-Keuls test.
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Experimental Group
Negative  
Control
Positive 
Control
MEST Pre-treatment Simultaneous Post-treatment
Animal’s weight
Inicial (g) 27.48 ± 1.57a 27.85 ± 0.72a 26.44 ± 0.43a 24.40 ± 1.04a 24.94 ± 1.09a 25.19 ± 0.44a
Final (g) 27.59 ± 1.27b 26.40 ± 0.41a,b 26.09 ± 0.40a,b 23.40 ± 0.85a 23.83 ± 0.95a 25.38 ± 0.38a,b
Liquid weight gain (g) 0.11 ± 0.71a -1.45 ± 0.39a -0.34 ± 0.14 a -1.00 ± 0.45 a -1.11 ± 0.21a 0.20 ± 0.11a
Absolute organ weight (g)
Heart 0.157 ± 0.010b,c 0.165 ± 0.006b,c 0.191 ± 0.010 c 0.146 ± 0.003b,c 0.131 ± 0.010a,b 0.141 ± 0.012b
Lung 0.249 ± 0.020a 0.202 ± 0.007a 0.211 ± 0.008a 0.237 ± 0.037a 0.179 ± 0.009a 0.210 ± 0.007a
Liver 1.659 ± 0.072c 1.553 ± 0.043b,c 1.527 ± 0.051b,c 1.468 ± 0.081b,c 1.327 ± 0.084a,b 1.549 ± 0.050b,c
Kidney 0.384 ± 0.019ª 0.411 ± 0.012a 0.360 ± 0.018a 0.349 ± 0.024a 0.333 ± 0.023a 0.364 ± 0.017a
Spleen 0.141 ± 0.007c 0.082 ± 0.003b 0.130 ± 0.006c 0.075 ± 0.003a,b 0.075 ± 0.004a,b 0.083 ± 0.004b
Relative organ weight (g)
Heart 0.005 ± 0.000a,b 0.006 ± 0.000a,b 0.007 ± 0.000b 0.006 ± 0000a,b 0.005 ± 0.000a 0.005 ± 0.000a
Lung 0.009 ± 0.000a 0.007 ± 0.000a 0.008 ± 0.000a 0.010 ± 0.001a 0.007 ± 0.000a 0.008 ± 0.000a
Liver 0.060 ± 0.003a 0.059 ± 0.002ª 0.058 ± 0.001a 0.062 ± 0.001a 0.055 ± 0.002a 0.061 ± 0.001a
Kidney 0.014 ± 0.000a 0.015 ± 0.000a 0.013 ± 0.000a 0.014 ± 0.000a 0.013 ± 0.000a 0.014 ± 0.000a
Spleen 0.005 ± 0.000b 0.003 ± 0.000a 0.005 ± 0.000b 0.003 ± 0.000a 0.003 ± 0.000a 0.003 ± 0.000a
MEST, Methanolic extract of S. terebinthifolius leaves; Mean ± S.E.M., Standard error of mean.  
Different letters mean significant differences (Statistical Test, Analysis of Variance - ANOVA/Tukey; p < 0.05).
Experimental  
Group
Damaged  
cells
Classes of DNA damage
Score DR%
0 1 2 3
Genotoxicity
Negative Control 30.0 ± 3.1a,b 64.0 ± 6.5c 34.4 ± 5.8a,b 1.6 ± 1.0a,b 0.0 ± 0.0a 37.6 ± 7.2a,b -
Positive Control 70.6 ± 5.0c 29.4 ± 5.0a 62.8 ± 4.7c 6.2 ± 1.7c 1.6 ± 0.9a 80.0 ± 6.2c -
MEST 15.2 ± 3.4a 84.7 ± 3.5c 14.5 ± 3.6a,b 0.5 ± 0.5a,b 0.2 ± 0.2a 16.2 ± 3.6a -
Antigenotoxicity
Pre-treatment 42.2 ± 6.5b,c 57.8 ± 6.5b,c 39.4 ± 6.2b,c 2.4 ± 0.8a-c 0.4 ± 0.2a 43.4 ± 6.9a,b 69.9
Simultaneous 66.5 ± 4.1c 33.5 ± 4.0a,b 65.7 ± 4.3c 0.7 ± 0.5a,b 0.0 ± 0.0a 67.2 ± 3.9b,c 10.0
Post-treatment 30.3 ± 12.4a,b 69.7 ± 12.5c 30.3 ± 12.5a,b 0.0 ± 0.0a 0.0 ± 0.0a 30.3 ± 12.4a 99.1
DR%, Percentage of Damage Reduction; MEST, Methanolic extract of S. terebinthifolius leaves; S.E.M., Standard error of mean.  
Different letters mean significant differences (Statistical Test, Analysis of Variance- ANOVA/Tukey; p < 0.05).
Experimental  
Group
MN frequency Mean ± SEM DR%
T1 T2 T3 T1 T2 T3 T1 T2 T3
Mutagenicity
Control 47 44 41 9.4 ± 0.9a 8.8 ± 0.7a 8.2 ± 1.0a - - -
Positive Control 229 224 178 45.8 ± 2.8c 44.8 ± 2.6d 35.6 ± 2.3d - - -
MEST 62 69 64 12.4 ± 0.9ª 13.8 ± 2.8a,b 12.8 ± 0.9a,b - - -
Antimutagenicity
Pre-treatment 208 132 97 41.6 ± 5.0c 26.4 ± 1.6c 19.4 ± 1.5c 11.5 51.1 66.4
Simultaneous 143 103 79 28.6 ± 1.7b 20.6 ± 1.8b,c 15.8 ± 1.6b,c 47.2 67.2 81.1
Post-treatment 127 71 48 25.4 ± 3.0b 14.2 ± 1.5a,b 9.6 ± 0.6a,b 56.0 85.0 106.5
MN, Micronucleus; S.E.M., Standard error of mean; %DR, Percentage of damage reduction; T1, T2, T3, collection time.  
Different letters mean significant differences (Statistical Test, Analysis of Variance - ANOVA/Tukey; p < 0.05).
Table 3
Initial, final and weight gain of the animals; absolute and relative weight of the organs of animals treated with Schinus 
terebinthifolius methanolic extract and /or cyclophosphamide.
Table 4
Mean frequency of damaged cells ± S.E.M., distribution among classes of damage and score related to genotoxicity and 
antigenotoxicity tests by the comet assay of peripheral blood of Swiss male mice.
Table 5
Total frequency, mean frequency ± S.E.M., percentage of damage reduction related to the tests for mutagenicity and 
antimutagenicity by micronucleus test of peripheral blood of Swiss male mice. 
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Experimental 
Group
Cells with evidence of phagocytosis
Mean ± S.E.M. Percentage (%)
Negative Control 111.8 ± 5.7b,c 55.9
Positive Control 68.8 ± 5.0a 34.4
MEST 138.3 ± 17.6c 69.1
Pre-treatment 98.4 ± 5.2a,b 49.2
Simultaneous 88.4 ± 3.3a,b 44.2
Post-treatment 82.0 ± 5.9a,b 41.0
MN, Micronucleus; S.E.M., Standard error of mean; %DR, Percentage of 
damage reduction; T1, T2, T3, collection time.  
Different letters mean significant differences (Statistical Test, Analysis 
of Variance - ANOVA/Tukey; p < 0.05).
Cell 
types
Reference 
values
Experimental Group
Negative 
Control
Positive 
Control
MEST Pre-treatment Simultaneous Post-treatment
Lymphocytes 55-95% 76 ± 5a-c 71 ± 4a-c 64 ± 3a 67 ± 4a,b 83 ± 2c 83 ± 2c
Neutrophils 10-40% 22 ± 4a-c 27 ± 4a-c 33 ± 3c 31 ± 4c 16 ± 2a,b 15 ± 2a
Monocytes 0.1-3.5% 0.4 ± 0.2a 1 ± 0.3a 0.2 ± 0.2a 0.4 ± 0.3a 0.2 ± 0.2a 0.4 ± 0.2a
Eosinophils 0-0.4% 1.4 ± 0.4a,b 0.4 ± 0.4a,b 1.8 ± 0.4b 0.8 ± 0.4a,b 0 ± 0a 0.8 ± 0.4a,b
Basophils 0-0.3% 0 ± 0a 0 ± 0a 0 ± 0 a 0 ± 0a 0 ± 0a 0 ± 0a
MEST, Methanolic extract of S. terebinthifolius leaves; S.E.M., Standard error of mean.  
Different letters mean significant differences (Statistical Test, Analysis of Variance - ANOVA/Tukey; p < 0.05).
Experimental Group
Liver Spleen Kidney
Mean ± S.E.M. Mean ± S.E.M. Mean ± S.E.M.
Negative Control 67.4 ± 13.7a,b 30.2 ± 4.9a 19.8 ± 1.7a
Positive Control 209.6 ± 21.5d 277.7 ± 14.3d 92.0 ± 10.7b
MEST 103.6 ± 7.5b,c 48.7 ± 5.9a,b 19.0 ±2.7a
Pre-treatment 232.2 ± 36.0d 103.6 ± 10.8c 159.8 ± 23.6c
Simultaneous 246.4 ± 12.4d 101.5 ± 10.7c 266.6 ± 21.1d
Post-treatment 181.2 ± 10.3c,d 72.8 ± 4.1b,c 97.4 ± 9.9b,c
MEST, Methanolic extract of S. terebinthifolius leaves; S.E.M., Standard error of mean.  
Different letters meansignificant differences (Statistical Test, Analysis of Variance - ANOVA/Tukey; p < 0.05). 
Table 6
Mean frequency ± S.E.M. and percentage of cells with 
evidence of splenic phagocytosis in Swiss mice.
Table 7
Mean frequency ± S.E.M. and percentage of cells with evidence of splenic phagocytosis in Swiss mice.
Table 8
Evaluation of apoptosis in liver, spleen and kidney of mice.
are induced with 80 mg/ml topical application of MEST. Our 
results showed that the extract obtained from S. terebinthifolius 
of Mato Grosso do Sul also induced wound healing. Moreover, 
the probable variation in chemical composition according to 
the part of plant (leaves) of S. terebinthifolius, culture and season 
did not influence this specific activity.
It is possible that MEST wound inhibition may be influenced 
by increase of inflammatory mediators (TNF-D, IL-1) and 
growth factors, as well as, inhibition of vascular permeability 
and leukocyte infiltration into the wound. To further confirm 
the role of MEST on leukocyte migration, experiments were 
carried out in an animal model of carrageenan-induced air 
pouch, which is a widely known model for massive leukocyte 
infiltration into artificially created pouches. MEST inhibition 
Both wound-healing and croton oil-induced edema tests 
are models used for the development of new drugs. There 
is great differences between these two models regarding 
duration: in the ear oedema model it is possible to analyze 
the anti-inflammatory effects of a product in a couple of 
hours (Tonelli et al., 1965); while the the biological effects 
of a product in the healing model can be evaluated after 15 
days (Nayak et al., 2013) or more. The topical application of 
croton produces oedema, cell infiltration and proliferation, 
production of prostanoids, leukotrienes, cytokines and other 
pro-inflammatory mediators (Patrick et al., 1987). The choice 
of lower doses for topical treatment of ear edema model 
was based on studies that showed that extracts from S. 
terebinthifolius in a systemic dose of 100 mg/kg exhibited effects 
of leukocyte migration and plasma leakage, observed in the 
air pouch model, are important parameters of inflammation. 
A recent work from our group showed that the essential oil 
obtained from S. terebinthifolius fruits also inhibited these 
two parameters in carrageenan-induced pleurisy in mice 
(Formagio et al., 2011). Maybe in whole parts of this plant the 
compounds responsible(s) for the anti-inflammatory activities 
are contained. These results contributed, at least in part, to 
explain the ability of S. terebinthifolius in folk medicine to 
combat the inflammatory and infectious diseases. Another 
important point of MEST activity is the demonstrated anti-
inflammatory efficacy of topical application of MEST in the 
croton oil-induced oedema in mice. These results showed that 
MEST contain bioactive compound(s) that elicit topical anti-
inflammatory effects in a dose-dependent manner.
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(Coutinho et al., 2006, Dos Santos et al., 2012). As expected, the 
present work showed that S. terebinthifolius extract inhibited 
ear edema at low doses of 0.1, 0.3, and 1 mg/ear. In contrast 
with low topical doses for ear edema, the dose for wound-
healing model, 4 mg per wound per day, was chosen because 
in the wound healing model not only inflammation will be 
important but also activated keratinocytes, fibroblasts, and 
endothelial cells in the injury, all of which increase their 
expression of several different metalloproteinases (MMP) 
classes such as collagenases (MMP-1, MMP-8), gelatinases 
(MMP-2, MMP-9), stromelysins (MMP-3, MMP-10, and MMP-
11), the membrane type MMP (MT1-MMP) and several agents 
other agents (Eming et al., 2007).  The topical treatment dose 
used of S. terebinthifolius extract induced healing. These results 
suggest that S. terebinthifolius extract elicits antiedematogenic 
and healing effects at different doses.
The phytochemical profile of S. terebinthifolius  is 
characterized by high content of tannins, gallic acid and 
flavonoids (Queires et al., 2006; Ceruks et al., 2007; Santana et 
al., 2012). The chemical constituents of the methanolic extract 
of the leaves of S. terebinthifolius by LC reported the presence 
of important bioactive components. It has been described 
in the literature that these compounds have antioxidant, 
anti-inflammatory, healing, antimutagenic and antitumor 
properties, as well as, considered chemical inhibitors of 
carcinogenesis (Sghaier et al., 2011). The presence of phenolic 
compounds was also demonstrated in a previous study 
conducted by our research group, with MEST (Fedel-Miyasato 
et al., 2014).
Taking this into account, the present study evaluated 
the MEST toxicogenic and chemopreventive activities. 
The results  have shown that  in  addit ion to  not 
presenting genotoxic and mutagenic properties, MEST 
has chemopreventive activities, and cyclophosphamide-
induced DNA damage reduction potential. The highest 
chemopreventive rate was observed in the post-treatment 
group, which presented a DR of 99.19% to genotoxic damage 
(T1) and 106.55% for mutagenic damage (T3), suggesting a 
preferential bio-antimutagenic activity mediated by repair 
enzymes (Kada and Shimoi, 1987; Antunes and Araújo, 2000; 
Oliveira et al., 2009), and the ability to reduce basal damage 
(Oliveira et al., 2002), a common event in chemoprevention 
studies (Oliveira et al., 2009). Our findings showed also, 
in lesser proportion, desmutagenic action observed in the 
pre-treatment group, which suggests the ability of MEST to 
inhibit compounds that cause DNA damage (Antunes and 
Araújo, 2000). Additionally, cyclophosphamide correlates 
to the process of immunosuppression (Ramadan et al., 
2012). The MEST group had an increased phagocytosis, 
which suggests immunostimulatory activity. Moreover, the 
extract associated with cyclophosphamide also contributed 
to splenic phagocytosis. It is noteworthy that the spleen 
is a lymphoid organ related to hemocatheresis, storage 
and release of cells into the bloodstream (Ramadan et al., 
2012). Therefore, the results of the phagocytic activity, 
when associated with antimutagenicity data suggest the 
phagocytosis of micronucleated cells by the spleen (Ishii 
et al., 2011). The present findings shows that, animals 
treated with cyclophosphamide exhibited an (I) increased 
frequency of micronuclei in peripheral blood; (II) decreased 
recruitment of macrophages by spleen, which determines 
the phagocytic activity reduction; and (III) a trend of 
increase of monocytes in circulation. Regarding the MEST-
treated group, no increase in the micronuclei frequency 
was observed. However, there is evidence of increased 
phagocytosis, which could be correlated to the decreased 
monocyte number in peripheral blood, since they may 
have migrated to the spleen. Furthermore an association 
between cyclophosphamide and MEST (T3) was observed; we 
suggest that the percentage of damage reduction was due 
to (I) the antimutagenic activity which may have prevented 
(desmutagenesis) and/or repaired (bioantimutagenesis) DNA 
damage; and (II) the sequestration of micronucleated cells 
by the spleen. These results also indicate that the lower 
phagocytic activity took place in the post- treatment group. 
This confirms the increased bioantimutagenesis activity 
promoted by MEST. This mode of action was previously 
described in the Allium cepa model by our research group 
(Fedel-Miyasato et al., 2014).
Apoptosis was increased in the liver, which may be 
related to the metabolism of cyclophosphamide, indirect-
acting agent, and the production of active metabolites that 
cause DNA damage leading to cell death (Ramadan et al., 
2012). The highest rates of apoptosis were found for Pre-
and Simultaneous treatment. This result is in accordance 
with the highest micronuclei frequency. Thus, it is suggested 
that MEST, besides being a chemopreventive agent, it is 
capable of stimulating the apoptosis of micronucleated 
cells. In addition, in the kidney was observed an increased 
apoptosis rate. It is known that this organ is responsible for 
blood filtration and removal of metabolic cyclophosphamide. 
Thus, it is suggested that the toxic product retention until 
the time of disposal could increase the rate of apoptosis in 
this organ.
The findings of this study indicate that MEST, in 
addition to treating inflammation and assisting the healing 
process, improves the integrity of the genetic material 
(chemopreventive activity), modulates splenic phagocytosis 
of mutated cells and increases the rate of apoptosis (Mauro 
et al., 2011). This latter fact is important for the development 
of new anti-inflammatory agents, since chemical-mediators 
such as cytokines, prostaglandins and leukotrienes, when 
produced in excess, may inhibit apoptosis (Barreto et al., 
2011), which could favor cancerous development (Valko et 
al., 2007; Formagio et al., 2013a,b). It is noteworthy that the 
chemopreventive activities observed for MEST, are associated 
with the antioxidant activities of phenolic constituents of the 
species (Queires et al., 2006; Ceruks et al., 2007; Santana et al., 
2012) that would be primarily responsible for the stability of 
the genetic material and for the resolution of inflammation.
In conclusion, our results showed that S. terebinthifolius 
presents significant wound-healing, anti-inflammatory and 
chemopreventive activities, which can be correlated with the 
prevention and/or treatment of degenerative diseases related to 
inflammation and mutagenic processes. This study also confirms 
that the extract of S. terebinthifolius can prevent and/or repair DNA 
damage by desmutagenic, and bioantimutagenesis processes. 
Further studies are needed to correlate the therapeutic properties 
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of the extract against the development of cancers originating 
from inflammatory processes, such as melanoma and colon 
cancer, and these are the next step of our research group.
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